These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 403146)

  • 21. Resistance of normal or immunized guinea pigs against a subcutaneous challenge of Brucella abortus.
    Pardon P; Marly J
    Ann Rech Vet; 1978; 9(3):419-25. PubMed ID: 107845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimental infection of dogs with Brucella abortus: effect of exposure dose on serologic responses and comparison of culture methods.
    Scanlan CM; Pidgeon GL; Richardson BE; Buening GM; Kemppainen RJ
    Cornell Vet; 1989 Jan; 79(1):93-107. PubMed ID: 2492215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An enzyme immunoassay for bovine brucellosis using a monoclonal antibody specific for field strains of Brucella abortus.
    Gorrell MD; Milliken GL; Anderson BJ; Pucci A
    Dev Biol Stand; 1984; 56():491-4. PubMed ID: 6436107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural, Functional, and Immunogenic Insights on Cu,Zn Superoxide Dismutase Pathogenic Virulence Factors from Neisseria meningitidis and Brucella abortus.
    Pratt AJ; DiDonato M; Shin DS; Cabelli DE; Bruns CK; Belzer CA; Gorringe AR; Langford PR; Tabatabai LB; Kroll JS; Tainer JA; Getzoff ED
    J Bacteriol; 2015 Dec; 197(24):3834-47. PubMed ID: 26459556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of Brucella abortus by immunofluorescence assay using anti outer membrane protein of 19 kDa antibody.
    Mohammadi E; Golchin M
    Adv Clin Exp Med; 2018 May; 27(5):643-648. PubMed ID: 29790689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistent plaque formation in experimental murine brucellosis.
    Schneerson-Porat S; Feinhaken D; Pinto M
    Comp Immunol Microbiol Infect Dis; 1983; 6(1):51-6. PubMed ID: 6402336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Partial protection against Brucella infection in mice by immunization with nonpathogenic alphaproteobacteria.
    Delpino MV; Estein SM; Fossati CA; Baldi PC
    Clin Vaccine Immunol; 2007 Oct; 14(10):1296-301. PubMed ID: 17715332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Influence of the mouse genotype on the sensitivity to Brucella abortus 544].
    Le Garrec Y; Garrido-Calderon N; Pilet C
    Dev Biol Stand; 1976; 31():287-92. PubMed ID: 816685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccination of Elk (Cervus canadensis) with Brucella abortus Strain RB51 Overexpressing Superoxide Dismutase and Glycosyltransferase Genes Does Not Induce Adequate Protection against Experimental Brucella abortus Challenge.
    Nol P; Olsen SC; Rhyan JC; Sriranganathan N; McCollum MP; Hennager SG; Pavuk AA; Sprino PJ; Boyle SM; Berrier RJ; Salman MD
    Front Cell Infect Microbiol; 2016; 6():10. PubMed ID: 26904509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on the relationship between Yersinia enterocolitica IX and Brucella abortus agglutinins in naturally infected animals.
    Mittal KR; Tizard IR
    Res Vet Sci; 1980 May; 28(3):311-4. PubMed ID: 6774395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
    Al-Mariri A; Tibor A; Mertens P; De Bolle X; Michel P; Godefroid J; Walravens K; Letesson JJ
    Infect Immun; 2001 Aug; 69(8):4816-22. PubMed ID: 11447155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study of serum bactericidal and splenic activity of Total-OMP- CagA combination from Brucella abortus and Helicobacter pylori in BALB/c mouse model.
    Abadi AH; Mahdavi M; Khaledi A; Esmaeili SA; Esmaeili D; Sahebkar A
    Microb Pathog; 2018 Aug; 121():100-105. PubMed ID: 29709690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A solid phase assay with radioactively-labelled antibody for the detection of Brucella abortus.
    Wilson DV; Thornley MJ; Coombs RR
    J Med Microbiol; 1977 Aug; 10(3):281-92. PubMed ID: 408491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brucella abortus 2308ΔNodVΔNodW double-mutant is highly attenuated and confers protection against wild-type challenge in BALB/c mice.
    Li Z; Wang S; Zhang J; Yang G; Yuan B; Huang J; Han J; Xi L; Xiao Y; Chen C; Zhang H
    Microb Pathog; 2017 May; 106():30-39. PubMed ID: 28131952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The immunomodulatory effect of antimicrobial peptide HPA3P restricts Brucella abortus 544 infection in BALB/c mice.
    Arayan LT; Kim HB; Bernardo Reyes AW; Xuan Huy NT; Hong IH; Lee K; Yeom JH; Park Y; Kim S
    Vet Microbiol; 2018 Nov; 225():17-24. PubMed ID: 30322527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Th2-related immune responses by the Brucella abortus cellular antigens, malate dehydrogenase, elongation factor, and arginase.
    Im YB; Shim S; Park WB; Kim S; Yoo HS
    Microb Pathog; 2017 Sep; 110():7-13. PubMed ID: 28629726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunization of BALB/c mice with Brucella abortus 2308ΔwbkA confers protection against wild-type infection.
    Li ZQ; Gui D; Sun ZH; Zhang JB; Zhang WZ; Zhang H; Guo F; Chen CF
    J Vet Sci; 2015; 16(4):467-73. PubMed ID: 26040616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody-mediated protection against Brucella abortus in BALB/c mice at successive periods after infection: variation between virulent strain 2308 and attenuated vaccine strain 19.
    Elzer PH; Jacobson RH; Jones SM; Nielsen KH; Douglas JT; Winter AJ
    Immunology; 1994 Aug; 82(4):651-8. PubMed ID: 7835931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
    Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
    Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Evaluation of antibrucellosis vaccines using guinea pigs].
    Le Garrec Y; Pilet C; Garrido-Calderon N
    Dev Biol Stand; 1976; 31():301-7. PubMed ID: 816686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.